NASDAQ: NAGE
Niagen Bioscience Inc Stock Ownership - Who owns Niagen Bioscience?

Insider buying vs selling

Have Niagen Bioscience Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ozan PamirChief Financial Officer2025-11-144,464$6.81
$30.40kBuy
Ozan PamirChief Financial Officer2025-11-142,220$6.85
$15.21kBuy
Robert N. FriedChief Executive Officer2025-04-0966,667$3.30
$220.00kBuy

1 of 1

NAGE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NAGE insiders and whales buy or sell their stock.

NAGE Shareholders

What type of owners hold Niagen Bioscience Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Hoi Shuen Solina Holly Chau32.06%25,672,139$123.23MInsider
Barry C. Honig26.40%21,143,044$101.49MInsider
Champion River Ventures Ltd24.16%19,349,652$92.88MInsider
Michael Brauser19.01%15,219,914$73.06MInsider
Frank L. Jaksch Jr.17.81%14,260,386$68.45MInsider
Phillip Md Et Al Frost15.74%12,602,939$60.49MInsider
Sheep Flp Black7.77%6,225,155$29.88MInsider
Tricia A. Jaksch7.77%6,225,155$29.88MInsider
Margie Chassman5.51%4,408,640$21.16MInsider
Blackrock Inc5.09%4,075,709$19.56MInstitution

1 of 3

NAGE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NAGE18.62%81.38%Net Buying
XFOR91.80%8.20%Net Buying
ENTA64.96%35.04%Net SellingNet Selling
CADL32.27%24.06%Net BuyingNet Buying
KYTX53.71%46.29%Net Buying

Niagen Bioscience Stock Ownership FAQ

Who owns Niagen Bioscience?

Niagen Bioscience (NASDAQ: NAGE) is owned by 40.19% institutional shareholders, 175.62% Niagen Bioscience insiders, and 0.00% retail investors. Hoi Shuen Solina Holly Chau is the largest individual Niagen Bioscience shareholder, owning 25.67M shares representing 32.06% of the company. Hoi Shuen Solina Holly Chau's Niagen Bioscience shares are currently valued at $122.46M.

If you're new to stock investing, here's how to buy Niagen Bioscience stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.